Rating History for NeuBase Therapeutics (NBSE) by RBC Capital
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/18/2022 | Brian Abrahams | Downgrade | Sector Perform (Outperform) |
1.00 (12.00) |
0.31 (0.38) |
22.58% | Details |
 |
|||||||
|
|||||||
